AABB Launches New Corporate Partner Program

July 28, 2021

AABB is pleased to announce the launch of its new Corporate Partner Program, designed to expand the Association’s offerings for corporate members of the blood and biotherapies community. 

The new program focuses on celebrating the vital work of corporate members of the community and offers them new and innovative avenues to connect with professionals in the field. It also offers the opportunity to work directly with AABB to help support education, resources and other tools that are critical for our community to grow and thrive.  

“Corporate members of the blood and biotherapies community have been a critical part of the field for many years and have helped spur advancements through innovations and support,” said Debra BenAvram, CEO of AABB. “AABB is pleased that our new Corporate Partner Program creates a novel way for this valuable part of our community to expand its engagement with our Association.”  

Five corporate partners have already joined the program as inaugural members: Ashland, Digi-Trax, GPI USA, Hemanext and Sanofi Genzyme. AABB thanks these Corporate Partners for their support of the Association and the field. 

For more information about the new AABB Corporate Partner Program, contact Margie Boraz